Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus

被引:9
作者
Kaatz, GW
Seo, SM
机构
[1] Wayne State Univ, Sch Med, Detroit VA Med Ctr C3690, Dept Internal Med,Div Infect Dis, Detroit, MI 48201 USA
[2] Dept Vet Affairs Med Ctr, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA
关键词
D O I
10.1128/AAC.42.1.197
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The incidence of the various mutations in the genes encoding topoisomerase IV and DNA gyrase in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus is not known. Using restriction fragment length polymorphism analysis and DNA sequencing, we found that in fluoroquinolone- and methicillin-resistant strains, mutations in grlA and gyrA are quite likely to be present together. For fluoroquinolone-resistant but methicillin-susceptible strains, mutations in grlA alone are more common.
引用
收藏
页码:197 / 198
页数:2
相关论文
共 11 条
[1]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[2]   CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES [J].
FERRERO, L ;
CAMERON, B ;
MANSE, B ;
LAGNEAUX, D ;
CROUZET, J ;
FAMECHON, A ;
BLANCHE, F .
MOLECULAR MICROBIOLOGY, 1994, 13 (04) :641-653
[3]   ANALYSIS OF GYRA AND GRLA MUTATIONS IN STEPWISE-SELECTED CIPROFLOXACIN-RESISTANT MUTANTS OF STAPHYLOCOCCUS-AUREUS [J].
FERRERO, L ;
CAMERON, B ;
CROUZET, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1554-1558
[4]   RAPID METHOD FOR EPIDEMIOLOGIC EVALUATION OF GRAM-POSITIVE COCCI BY FIELD INVERSION GEL-ELECTROPHORESIS [J].
GOERING, RV ;
WINTERS, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :577-580
[5]   DETECTION OF GYRA GENE-MUTATIONS ASSOCIATED WITH CIPROFLOXACIN RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - ANALYSIS BY POLYMERASE CHAIN-REACTION AND AUTOMATED DIRECT DNA SEQUENCING [J].
GOSWITZ, JJ ;
WILLARD, KE ;
FASCHING, CE ;
PETERSON, LR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1166-1169
[6]   EFFLUX-MEDIATED FLUOROQUINOLONE RESISTANCE IN STAPHYLOCOCCUS-AUREUS [J].
KAATZ, GW ;
SEO, SM ;
RUBLE, CA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1086-1094
[7]  
National Committee for Clinical Laboratory Standards, 1993, METH DIL ANT SUSC TE
[8]   Quinolone resistance mutations in topoisomerase IV: Relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus [J].
Ng, EY ;
Trucksis, M ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1881-1888
[9]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[10]   DNA GYRASE GYRA MUTATIONS IN CIPROFLOXACIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS - CLOSE SIMILARITY WITH QUINOLONE RESISTANCE MUTATIONS IN ESCHERICHIA-COLI [J].
SREEDHARAN, S ;
ORAM, M ;
JENSEN, B ;
PETERSON, LR ;
FISHER, LM .
JOURNAL OF BACTERIOLOGY, 1990, 172 (12) :7260-7262